acquisition
Happy Stock Photo / shutterstock.com
11 August 2016Big Pharma

Pharming to acquire rights for Ruconest

Pharming Group, a Netherlands based company, has agreed to buy the North American commercialisation rights to its drug Ruconest (recombinant human C1 esterase inhibitor) from Valeant Pharmaceuticals.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk